Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)

Clinical trial NCT03040791 · UNKNOWN

Trial details

NCT number: NCT03040791
Sponsor: Hospital Moinhos de Vento
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2018-06-01
Primary completion: 2022-01-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.